|

Anti-CD19-CD3E-CAR-T cells Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Shanghai Changzheng Hospital1

Indications

  • ANCA Associated Vasculitis1
  • Inflammatory Myopathy1
  • Antiphospholipid Syndrome1
  • Systemic Sclerosis1
  • Sjogren's Syndrome1

Other1 trial

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.